Addiction Medicine: Beyond the Abstract

American Society of Addiction Medicine

Learn more about the perspectives behind formal research articles! In Journal of Addiction Medicine: Beyond the Abstract, hosts Shawn McNeil and Zach Caruso interview authors recently published in the Journal of Addiction Medicine, detailing their research process, summarizing key findings from their work, and identifying future areas of research. Hosted by Journal Podcast Editor, Shawn McNeil, MD, and ASAM Media Manager Zach Caruso.

  1. FEB 6

    Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

    In this episode of Beyond The Abstract, Dr. Matthew Sloan sits down to discuss findings from his recent article Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine featured in the November/December issue of the Journal of Addiction Medicine. Join us as Dr. Sloan shares insights into his study investigating the feasibility of delivering symptom-triggered alcohol withdrawal management over telemedicine.   Dr. Matthew Sloan is a clinician scientist at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. He specializes in the treatment of substance use disorders and their psychiatric comorbidities. He completed medical school and psychiatry residency at McGill University followed by a postdoctoral fellowship in human psychopharmacology at the National Institutes of Health and an addiction psychiatry fellowship at Yale University. Dr. Sloan's primary research interests are developing innovative new treatments for substance use disorders and exploring determinants of psychopharmacological response to drugs of misuse. He has obtained competitive research funding from the Canadian Institutes of Health Research, Health Canada, and the Centre for Addiction and Mental Health Discovery Fund and has received scientific prizes from the American Academy of Addiction Psychiatry and the National Institute on Alcohol Abuse and Alcoholism.   Article Link: Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

    13 min
  2. 09/18/2025

    Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative

    Dr. Pouya Azar stops by the show to talk about his recent article Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative. He discusses the potential benefits of transitioning patients with opioid use disorder from traditional to extended-release or long-acting buprenorphine within 7 days or 24 hours, respectively, of treatment, as well as challenges and future questions that arose from his narrative review. Pouya Azar, MD, FRCPC, DABAM, is a clinician-scientist in addiction psychiatry and pain medicine based in Vancouver, British Columbia, Canada. He serves as co-medical manager of the Complex Pain and Addiction Service (CPAS) at Vancouver Coastal Health, a consult service providing management of pain, mental health disorders, and substance use disorders across Vancouver General Hospital, the University of British Columbia (UBC) Hospital, and GF Strong Rehabilitation Centre. He is also an assistant professor (tenure-track) in the UBC Department of Psychiatry, research scientist co-lead of the Substance Use Disorder Clinical Research Unit at the BC Centre for Excellence in HIV/AIDS, and a physician at the Vancouver General Hospital Transitional Pain Clinic. Dr. Azar’s clinical and translational research focuses on developing novel opioid agonist treatment initiation and withdrawal management protocols, medical devices, digital health apps, and prevention programs to improve patient outcomes. - Article Link: Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative

    26 min

Ratings & Reviews

4.8
out of 5
31 Ratings

About

Learn more about the perspectives behind formal research articles! In Journal of Addiction Medicine: Beyond the Abstract, hosts Shawn McNeil and Zach Caruso interview authors recently published in the Journal of Addiction Medicine, detailing their research process, summarizing key findings from their work, and identifying future areas of research. Hosted by Journal Podcast Editor, Shawn McNeil, MD, and ASAM Media Manager Zach Caruso.

You Might Also Like